Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis

Introduction: Therapeutic targeting of inhibitors of the immune response has reached the clinical setting. Inhibitors of the novel receptor LAG3, which negatively regulates T-cell activation, are under investigation. Here we explore the presence and prognostic role of LAG3 in cancer.Methods: A syste...

Full description

Bibliographic Details
Main Authors: Ramy R. Saleh, Paloma Peinado, Jesús Fuentes-Antrás, Pedro Pérez-Segura, Atanasio Pandiella, Eitan Amir, Alberto Ocaña
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01040/full